KJ was born into a fight he never chose. 💔
Diagnosed with severe CPS1 deficiency, a rare and life-threatening metabolic disorder, his body couldn’t safely process nitrogen—turning every moment into a medical emergency.

For his family, time wasn’t just important…
it was everything. ⏳

With such conditions, even small delays can become dangerous.
And in those early days, the future felt uncertain, fragile, and frightening.

But then—something extraordinary happened.

Doctors at Children’s Hospital of Philadelphia and Penn Medicine came together to do what had never been done before. 🏥
They created a personalized CRISPR gene-editing therapy, designed specifically for KJ—targeting the exact genetic mutation causing his illness. 🧬✨

This wasn’t just treatment.
It was precision medicine at its most powerful—
not managing symptoms, but going straight to the source.

KJ became the first known patient to receive this kind of customized gene-editing therapy.

And incredibly…
he responded positively. 🌟

His story is more than a medical milestone.
It is a moment where science met urgency—
where innovation moved fast enough to save a life.